Table 2.
Crystal violet assay | ||||
---|---|---|---|---|
MRSA vs MSSA | P. aeruginosa R vs S | |||
Prevention of biofilm formation | Treatment of pre-formed biofilm | Prevention of biofilm formation | Treatment of pre-formed biofilm | |
CQ ½ MIC | p<0.005 | p<0.01 | - | p<0.001 |
CQ ¼ MIC | p<0.01 | p<0.01 | - | p<0.001 |
GEN ½ MIC | - | - | - | - |
GEN ¼ MIC | - | - | - | p<0.005 |
FA ½ MIC | - | - | ||
FA ¼ MIC | - | - | ||
CLSM assay | ||||
MRSA vs MSSA | P. aeruginosa R vs S | |||
Prevention of biofilm formation | Treatment of pre-formed biofilm | Prevention of biofilm formation | Treatment of pre-formed biofilm | |
CQ ½ MIC | p<0.01 | p<0.01 | p<0,001 | p<0.001 |
CQ ¼ MIC | p<0.01 | - | - | p<0.005 |
GEN ½ MIC | - | - | - | - |
GEN ¼ MIC | - | - | - | - |
FA ½ MIC | - | - | ||
FA ¼ MIC | - | - |
Notes: S, P. aeruginosa susceptible to carbapenems, R, P. aeruginosa resistant to carbapenems.
Abbreviations: CLSM, Confocal laser scanning microscopy; CQ, chlorquinaldol; GEN, gentamicin; FA, fusidic acid; MRSA, methicillin resistant Staphylococcus aureus; MSSA, methicillin susceptible Staphylococcus aureus.